Truist initiated coverage of Synovus (SNV) with a Buy rating and $56 price target The bank, which the firm sees as in the “middle innings” of a self-help journey, is focused on investing in organic growth and delivering top-tier profitability with improved credit quality, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
- Synovus price target lowered to $48 from $52 at Evercore ISI
- Synovus price target lowered to $60 from $65 at DA Davidson
- Synovus price target lowered to $52 from $64 at RBC Capital
- Synovus price target lowered to $46 from $52 at Stephens
- Synovus price target lowered to $52 from $58 at Keefe Bruyette